MediWound Ltd.
NASDAQ:MDWDBiotechnology
Healthcare
$13.68 -0.60%
-$0.09 today
- Market cap
- $176.61M
- Beta
- 0.15
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$2.03
52W Low $13.54High $21.26
Volume 0.16M
Average 0.09M
Income Statement
Follow revenue through to earnings.
Revenue
$16.96M
FY 2025 · Annual
-16.1% YoYOperating Income
-$25.28M
FY 2025 · Annual
Net Income
-$23.88M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 23.76M | 26.5M | 18.69M | 20.22M | 16.96M |
| Cost of Revenue | 14.99M | 13.33M | 15.11M | 17.59M | 13.71M |
| Gross Profit | 8.77M | 13.17M | 3.58M | 2.63M | 3.25M |
| Gross Margin | 36.9% | 49.7% | 19.1% | 13.0% | 19.2% |
| Research & Development | 10.26M | 10.18M | 7.47M | 8.88M | 14.32M |
| Selling, General & Admin | 9.45M | 10.37M | 11.38M | 12.91M | 13.93M |
| Operating Expenses | 19.99M | 20.83M | 19.08M | 22.02M | 28.53M |
| Depreciation & Amortization | 1.24M | 1.27M | 1.3M | 1.48M | 1.86M |
| EBITDA | (11.38M) | (18.25M) | (4.8M) | (27.93M) | (21.47M) |
| EBITDA Margin | -47.9% | -68.9% | -25.7% | -138.1% | -126.6% |
| Operating Income | (11.22M) | (7.66M) | (15.5M) | (19.38M) | (25.28M) |
| Operating Margin | -47.2% | -28.9% | -83.0% | -95.8% | -149.1% |
| Interest Income | 11K | 270K | 2.34M | 2.05M | 1.86M |
| Interest Expense | 167K | 162K | 335K | 561K | 663K |
| Other Income / Expenses | (2.3M) | (11.86M) | 8.97M | (10.78M) | 1.57M |
| Income Before Tax | (13.52M) | (19.52M) | (6.53M) | (30.16M) | (23.71M) |
| Pre-Tax Margin | -56.9% | -73.7% | -35.0% | -149.2% | -139.8% |
| Income Tax Expense | 27K | 78K | 185K | 61K | 169K |
| Net Income | (13.55M) | (19.6M) | (6.72M) | (30.22M) | (23.88M) |
| Net Margin | -57.0% | -74.0% | -35.9% | -149.5% | -140.8% |
| EPS (Basic) | (3.48) | (3.93) | (0.75) | (3.03) | (2.10) |
| EPS (Diluted) | (3.48) | (3.93) | (0.75) | (3.03) | (2.10) |
| 3.89M | 4.99M | 9.01M | 9.96M | 11.38M | |
| 3.89M | 4.99M | 9.01M | 9.96M | 11.38M |
MDWD Earnings Waterfall · TTM
NASDAQ:MDWD · Revenue to Net Income
Key Ratios
EPS$-2.26
Gross Margin19.2%
Net Margin-216.8%
P/E Ratio-12.1
P/S Ratio85.2
Analysis
$14.5M of revenue converted into -$26.1M of net income for the selected period. Gross margin is 19.2% and net margin is -216.8%, showing how much revenue survives after costs and taxes. EPS is $-2.26, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 6-K | 6-K filing | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 |
How much revenue does MDWD generate?
MediWound Ltd. (MDWD) reported $16.96M of revenue in fiscal 2025.
Is MDWD profitable?
MediWound Ltd. (MDWD) reported -$23.88M of net income, with a net margin of -140.8%.
Continue the stock analysis
Jump to another research area for this company.